$SEER

Seer, Inc.

alphai earnings readSecond Quarter 2026 · AUG 11Seer Reports Second Quarter 2026 Financial Results and Reaffirms Full Year 2026 OutlookVerdict: weak

Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.

No enriched coverage for $SEER in the last 7 days.

$15K
Horn David R.
0%
See all $SEER insider activity →
Med

Seer (SEER) Q2 2026 Earnings Call Transcript

Seer (SEER) reported Q2 2026 earnings, highlighting $209.5M in cash reserves and strategic investments, including share repurchases totaling 13.4M shares. The company emphasized scientific validation of its Proteograph Product Suite, with 95 publications supporting its platform. Key studies demonstrated Proteograph's superior performance in proteomics, reinforcing its value proposition and potential for revenue growth. Seer also announced plans to leverage AI for disease detection and highlighte

Seer Inc. Q2 2026 Earnings: Revenue Misses $3.1 Million

Seer Inc. (Nasdaq: SEER) reported Q2 2026 revenue of $3.1 million, below consensus of $4.0 million, and a net loss of $0.31 per share versus a $0.22 loss expected. The company reaffirmed full-year 2026 revenue guidance of $16 million to $18 million. Shares fell about 2.78% after hours to $2.10.

Seer (SEER) Stock Faces Revenue Slump As Losses Stay Heavy

Simply Wall St reports Seer (SEER) shares fell about 2% to $2.10 after its Q2 results. The company posted revenue of $3.1M, down 23.4% year over year, and a net loss of $16.9M. Cash and investments were $209.5M. Gross margin eased to 49% from 52%, while 2026 guidance implies low single digit growth.

SEER sentiment & insider activity

Recent SEER coverage spans earnings, mergers & acquisitions and market movers.

In the last 30 days, SEER insiders filed 1 SEC Form 4 transaction — no purchases and 1 sale ($15K). The most active reporter was Horn David R., PRESIDENT & CFO, with 1 filing.

What's driving SEER

  • The transcript is bullish on platform validation and IP enforcement, but it provides no fresh revenue guidance or quantified financial results in the excerpt.

    yahoo.com · Aug 19, 2026

  • Earnings miss with reaffirmed FY outlook suggests near-term demand softness but some cost-control support.

    sci-tech-today.com · Aug 14, 2026

  • The earnings snapshot highlights worsening top-line momentum and persistent losses, raising valuation-risk concerns around the 8.2x P/S multiple.

    simplywall.st · Aug 13, 2026

  • Guidance reaffirmation plus a near-term HUPO data catalyst can support a re-rating, but funding hesitancy and litigation keep risk elevated.

    yahoo.com · Aug 13, 2026

  • The 8-K provides fresh quarterly financials, cash position, and reiterated FY revenue range, shaping near-term valuation and risk appetite.

    SEC EDGAR 8-K · Aug 11, 2026

alphai scores every news story that mentions SEER with an AI model for sentiment and relevance, and aggregates insider trades from Seer, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $SEER

Score
$SEERMed

Seer (SEER) Q2 2026 Earnings Call Transcript

Seer (SEER) reported Q2 2026 earnings, highlighting $209.5M in cash reserves and strategic investments, including share repurchases totaling 13.4M shares. The company emphasized scientific validation of its Proteograph Product Suite, with 95 publications supporting its platform. Key studies demonstrated Proteograph's superior performance in proteomics, reinforcing its value proposition and potential for revenue growth. Seer also announced plans to leverage AI for disease detection and highlighte

$SEERMedAI 8/10

Seer Inc. Q2 2026 Earnings: Revenue Misses $3.1 Million

Seer Inc. (Nasdaq: SEER) reported Q2 2026 revenue of $3.1 million, below consensus of $4.0 million, and a net loss of $0.31 per share versus a $0.22 loss expected. The company reaffirmed full-year 2026 revenue guidance of $16 million to $18 million. Shares fell about 2.78% after hours to $2.10.

$SEERMed

Seer (SEER) Stock Faces Revenue Slump As Losses Stay Heavy

Simply Wall St reports Seer (SEER) shares fell about 2% to $2.10 after its Q2 results. The company posted revenue of $3.1M, down 23.4% year over year, and a net loss of $16.9M. Cash and investments were $209.5M. Gross margin eased to 49% from 52%, while 2026 guidance implies low single digit growth.

$SEERMed

Seer, Inc. Q2 2026 Earnings Call Summary

Seer, Inc. reported Q2 2026 revenue of $3.1 million, up $0.3 million sequentially, and reaffirmed full-year 2026 guidance of $16 million to $18 million. Management cited deep proteomics positioning for AI, IP wins, and cash of $209.5 million. Gross margin rose to 49%.

$SEERMedAI 8/10

Seer, Inc. (SEER): Results of Operations and Financial Condition

Seer, Inc. (SEER) filed an SEC Form 8-K — Results of Operations and Financial Condition. Seer Reports Second Quarter 2026 Financial Results and Reaffirms Full Year 2026 Outlook REDWOOD CITY, Calif. – August 11, 2026 – Seer, Inc. (Nasdaq: SEER) (“Seer” or the “Company”), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced financial r

SEER Robotics Reports Over 460 Percent Year-over-Year Growth in Overseas New Orders in the First Five Months of 2026

SEER Robotics said overseas new orders rose more than 460% year over year in Jan-May 2026 and its overseas customer base expanded. The company cites CIC rankings for intelligent robot controllers, including 24.8% global market share in 2025. It reported revenue of RMB 249 million (2023) to RMB 442 million (2025), gross margin 47.4% in 2025, and gross margins above 80% for core controllers.

$SEERLow

Seer, Inc. (SEER): Submission of Matters to a Vote of Security Holders

Seer, Inc. (SEER) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. Seer Announces Receipt of Unsolicited Acquisition Proposal from Omid Farokhzad, M.D. No Stockholder Action Required at This Time REDWOOD CITY, Calif. – July 2, 2026 – Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced

$SEERMedAI 8/10

Two Revised, Non-Binding Proposals Seek to Acquire All of Seer's Class A Shares

Seer Confirms Receipt of Further Revised Unsolicited Acquisition Proposals From Radoff-JEC Group and From Omid Farokhzad, M.D. Rhea-AI Summary Seer (Nasdaq: SEER) confirmed receipt of two further revised, unsolicited, non-binding acquisition proposals for all outstanding shares of its Class A common stock. On July 28, 2026, the Radoff-JEC Group offered $2.55 per share in cash plus a contingent value right.

Related tickers